Two Sigma Securities’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,826
| Closed | -$77.6K | – | 1408 |
|
|
2024
Q4 | $77.6K | Buy |
40,826
+27,517
| +207% | +$52.3K | 0.01% | 951 |
|
|
2024
Q3 | $17.6K | Buy |
+13,309
| New | +$17.6K | ﹤0.01% | 1270 |
|
|
2024
Q2 | – | Sell |
-32,073
| Closed | -$58.7K | – | 1499 |
|
|
2024
Q1 | $58.7K | Buy |
32,073
+20,202
| +170% | +$37K | ﹤0.01% | 1056 |
|
|
2023
Q4 | $14.7K | Sell |
11,871
-5,032
| -30% | -$6.24K | ﹤0.01% | 1201 |
|
|
2023
Q3 | $19.3K | Sell |
16,903
-8,382
| -33% | -$9.56K | ﹤0.01% | 1040 |
|
|
2023
Q2 | $23.1K | Sell |
25,285
-112,752
| -82% | -$103K | ﹤0.01% | 972 |
|
|
2023
Q1 | $77.4K | Buy |
138,037
+54,269
| +65% | +$30.4K | ﹤0.01% | 936 |
|
|
2022
Q4 | $48.3K | Buy |
83,768
+57,634
| +221% | +$33.3K | ﹤0.01% | 963 |
|
|
2022
Q3 | $8K | Sell |
26,134
-9,465
| -27% | -$2.9K | ﹤0.01% | 1213 |
|
|
2022
Q2 | $13K | Buy |
35,599
+3,430
| +11% | +$1.25K | ﹤0.01% | 1054 |
|
|
2022
Q1 | $23K | Sell |
32,169
-742
| -2% | -$531 | ﹤0.01% | 962 |
|
|
2021
Q4 | $74K | Buy |
32,911
+11,550
| +54% | +$26K | ﹤0.01% | 716 |
|
|
2021
Q3 | $62K | Buy |
+21,361
| New | +$62K | ﹤0.01% | 682 |
|
|
2021
Q2 | – | Sell |
-14,046
| Closed | -$48K | – | 690 |
|
|
2021
Q1 | $48K | Buy |
+14,046
| New | +$48K | ﹤0.01% | 509 |
|
|
2020
Q1 | – | Sell |
-30,694
| Closed | -$194K | – | 619 |
|
|
2019
Q4 | $194K | Buy |
+30,694
| New | +$194K | ﹤0.01% | 597 |
|
|
2019
Q1 | – | Sell |
-10,285
| Closed | -$57K | – | 831 |
|
|
2018
Q4 | $57K | Buy |
+10,285
| New | +$57K | ﹤0.01% | 972 |
|